• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大不列颠哥伦比亚省艾滋病预防和护理工作的历史回顾:1996-2015 年。

A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.

机构信息

BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada.

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

出版信息

J Int AIDS Soc. 2017 Sep 19;20(1):21941. doi: 10.7448/IAS.20.1.21941.

DOI:10.7448/IAS.20.1.21941
PMID:28953322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5640311/
Abstract

INTRODUCTION

British Columbia has made significant progress in the treatment and prevention of HIV since 1996, when Highly Active Antiretroviral Therapy (HAART) became available. However, we currently lack a historical summary of HIV prevention and care interventions implemented in the province since the introduction of HAART and how they have shaped the HIV epidemic. Guided by a socio-ecological framework, we present a historical review of biomedical and health services, community and structural interventions implemented in British Columbia from 1996-2015 to prevent HIV transmission or otherwise enhance the cascade of HIV care.

METHODS

We constructed a historical timeline of HIV interventions implemented in BC between 1996 and 2015 by reviewing publicly available reports, guidelines and other documents from provincial health agencies, community organizations and AIDS service organizations, and by conducting searches of peer-reviewed literature through PubMed and Ovid MEDLINE. We collected further programmatic information by administering a data collection form to representatives from BC's regional health authorities and an umbrella agency representing 45 AIDS Service organizations. Using linked population-level health administrative data, we identified key phases of the HIV epidemic in British Columbia, as characterized by distinct changes in HIV incidence, HAART uptake and the provincial HIV response.

RESULTS AND DISCUSSION

In total, we identified 175 HIV prevention and care interventions implemented in BC from 1996 to 2015. We identify and describe four phases in BC's response to HIV/AIDS: the early HAART phase (1996-1999); the harm reduction and health service scale-up phase (2000-2005); the early Treatment as Prevention phase (2006-2009); and the STOP HIV/AIDS phase (2010-present). In doing so, we provide an overview of British Columbia's universal and centralized HIV treatment system and detail the role of community-based and provincial stakeholders in advancing innovative prevention and harm reduction approaches, as well as "seek, test, treat and retain" strategies.

CONCLUSIONS

The review provides valuable insight into British Columbia's HIV response, highlights emerging priorities, and may inform future efforts to evaluate the causal impact of interventions.

摘要

简介

自 1996 年高效抗逆转录病毒疗法(HAART)问世以来,不列颠哥伦比亚省在艾滋病毒的治疗和预防方面取得了重大进展。然而,我们目前缺乏自 HAART 引入以来在该省实施的艾滋病毒预防和护理干预措施的历史总结,以及它们如何影响艾滋病毒流行。本研究以社会生态学框架为指导,回顾了 1996 年至 2015 年不列颠哥伦比亚省实施的生物医学和卫生服务、社区和结构干预措施,以防止艾滋病毒传播或增强艾滋病毒护理的传播。

方法

我们通过查阅省级卫生机构、社区组织和艾滋病服务组织提供的公开报告、指南和其他文件,以及通过 PubMed 和 Ovid MEDLINE 对同行评议文献进行搜索,构建了 1996 年至 2015 年不列颠哥伦比亚省实施的艾滋病毒干预措施的历史时间表。我们通过向不列颠哥伦比亚省地区卫生当局和代表 45 个艾滋病服务组织的伞式机构的代表发放数据收集表,收集了进一步的项目信息。利用关联的人群健康管理数据,我们确定了不列颠哥伦比亚省艾滋病毒流行的关键阶段,其特征是艾滋病毒发病率、HAART 使用率和省级艾滋病毒应对措施的显著变化。

结果和讨论

共确定了 1996 年至 2015 年在不列颠哥伦比亚省实施的 175 项艾滋病毒预防和护理干预措施。我们确定并描述了不列颠哥伦比亚省对艾滋病毒/艾滋病的四种反应阶段:早期 HAART 阶段(1996-1999 年);减少危害和扩大卫生服务阶段(2000-2005 年);早期治疗即预防阶段(2006-2009 年);以及“停止艾滋病毒/艾滋病”阶段(2010 年至今)。这样做的同时,我们概述了不列颠哥伦比亚省的普遍和集中的艾滋病毒治疗系统,并详细介绍了社区和省级利益攸关方在推进创新的预防和减少危害方法以及“发现、检测、治疗和保留”战略方面的作用。

结论

该综述提供了不列颠哥伦比亚省艾滋病毒应对措施的宝贵见解,突出了新出现的重点,并可能为评估干预措施的因果影响提供未来努力的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/8270a129d4cc/ZIAS_A_1371937_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/a4683d82403e/ZIAS_A_1371937_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/4e66c0736f86/ZIAS_A_1371937_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/6e4ed8a099fb/ZIAS_A_1371937_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/8270a129d4cc/ZIAS_A_1371937_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/a4683d82403e/ZIAS_A_1371937_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/4e66c0736f86/ZIAS_A_1371937_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/6e4ed8a099fb/ZIAS_A_1371937_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b79e/5640311/8270a129d4cc/ZIAS_A_1371937_F0004_C.jpg

相似文献

1
A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.加拿大不列颠哥伦比亚省艾滋病预防和护理工作的历史回顾:1996-2015 年。
J Int AIDS Soc. 2017 Sep 19;20(1):21941. doi: 10.7448/IAS.20.1.21941.
2
Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.1996-2013 年加拿大不列颠哥伦比亚省抗逆转录病毒疗法和减少伤害措施对 HIV 发病率的相对影响:建模研究。
Lancet HIV. 2017 Jul;4(7):e303-e310. doi: 10.1016/S2352-3018(17)30045-0. Epub 2017 Mar 30.
3
The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.加拿大不列颠哥伦比亚省的 HIV 护理级联,1996-2011:一项基于人群的回顾性队列研究。
Lancet Infect Dis. 2014 Jan;14(1):40-49. doi: 10.1016/S1473-3099(13)70254-8. Epub 2013 Sep 27.
4
Longitudinal evolution of the HIV effective reproduction number following sequential expansion of treatment as prevention and pre-exposure prophylaxis in British Columbia, Canada: a population-level programme evaluation.加拿大不列颠哥伦比亚省在相继扩大治疗即预防和暴露前预防措施后,艾滋病毒有效繁殖数的纵向演变:基于人群的方案评估。
Lancet HIV. 2024 Jul;11(7):e461-e469. doi: 10.1016/S2352-3018(24)00094-8. Epub 2024 Jun 4.
5
Cohort profile: Seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC).队列简介:在不列颠哥伦比亚省寻求并治疗以实现对艾滋病毒/艾滋病的最佳预防(不列颠哥伦比亚省艾滋病毒/艾滋病防治项目)
Int J Epidemiol. 2014 Aug;43(4):1073-81. doi: 10.1093/ije/dyu070. Epub 2014 Apr 2.
6
Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada.在加拿大不列颠哥伦比亚省开展全省治疗即预防倡议前后,诊断出 HIV 的人群的医疗保健和治疗体验。
BMC Public Health. 2022 May 21;22(1):1022. doi: 10.1186/s12889-022-13415-2.
7
Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005.不列颠哥伦比亚省艾滋病毒/艾滋病感染者的迁移的区域和时间趋势,1993-2005 年。
Can J Public Health. 2010 Jan-Feb;101(1):44-9. doi: 10.1007/BF03405561.
8
Disparities in multimorbidity and mortality among people living with and without HIV across British Columbia's health regions: a population-based cohort study.不列颠哥伦比亚省各卫生区域内 HIV 感染者与非感染者的共病和死亡率差异:一项基于人群的队列研究。
Can J Public Health. 2021 Dec;112(6):1030-1041. doi: 10.17269/s41997-021-00525-4. Epub 2021 Aug 30.
9
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.加拿大不列颠哥伦比亚省高效抗逆转录病毒治疗覆盖率、人群病毒载量与每年新增 HIV 诊断病例的关联:一项基于人群的研究。
Lancet. 2010 Aug 14;376(9740):532-9. doi: 10.1016/S0140-6736(10)60936-1. Epub 2010 Jul 16.
10
Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada.队列特征描述:加拿大不列颠哥伦比亚省 STOP HIV/AIDS 计划评估(SHAPE)研究。
BMJ Open. 2020 May 12;10(5):e033649. doi: 10.1136/bmjopen-2019-033649.

引用本文的文献

1
Generalized Treatment as Prevention Plus Focused Pre-Exposure Prophylaxis Is the Key to Controlling HIV/AIDS.将普遍治疗作为预防措施加上针对性的暴露前预防是控制艾滋病毒/艾滋病的关键。
Trop Med Infect Dis. 2025 Mar 12;10(3):75. doi: 10.3390/tropicalmed10030075.
2
Life expectancy and mortality among males and females with HIV in British Columbia in 1996-2020: a population-based cohort study.1996 - 2020年不列颠哥伦比亚省感染艾滋病毒的男性和女性的预期寿命和死亡率:一项基于人群的队列研究。
Lancet Public Health. 2025 Mar;10(3):e228-e236. doi: 10.1016/S2468-2667(24)00304-9. Epub 2025 Feb 6.
3
Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada.

本文引用的文献

1
Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.1996-2013 年加拿大不列颠哥伦比亚省抗逆转录病毒疗法和减少伤害措施对 HIV 发病率的相对影响:建模研究。
Lancet HIV. 2017 Jul;4(7):e303-e310. doi: 10.1016/S2352-3018(17)30045-0. Epub 2017 Mar 30.
2
Universal Coverage without Universal Access: Institutional Barriers to Health Care among Women Sex Workers in Vancouver, Canada.全民医保却非全民可及:加拿大温哥华女性性工作者获取医疗保健的制度性障碍
PLoS One. 2016 May 16;11(5):e0155828. doi: 10.1371/journal.pone.0155828. eCollection 2016.
3
加拿大不列颠哥伦比亚省全省范围内开展暴露前预防(PrEP)项目的艾滋病预防监测指标的制定过程描述。
PLoS One. 2023 Mar 15;18(3):e0283025. doi: 10.1371/journal.pone.0283025. eCollection 2023.
4
Precarious Housing Associated with Unsuppressed Viral load, sub-optimal Access to HIV Treatment and Unmet Health care Needs, Among Women Living with HIV in Metro Vancouver, Canada.在加拿大温哥华都会区,与不稳定住房相关的因素包括病毒载量未得到抑制、获得 HIV 治疗的机会不理想以及未能满足医疗保健需求等,这些因素对感染 HIV 的女性产生影响。
AIDS Behav. 2023 Jul;27(7):2271-2284. doi: 10.1007/s10461-022-03957-2. Epub 2023 Feb 2.
5
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials.综合性针具与注射器方案和阿片类激动剂治疗在不同环境下减少了注射吸毒者中 HIV 和丙型肝炎病毒的感染:模拟试验的汇总分析。
Addiction. 2023 Jun;118(6):1116-1126. doi: 10.1111/add.16147. Epub 2023 Feb 13.
6
Multilevel model in the identification of behavioral and structural risk factors for HIV: integrative review.多层次模型在识别 HIV 的行为和结构风险因素中的应用:综合评价。
Rev Bras Enferm. 2022 Dec 16;76(1):e20210853. doi: 10.1590/0034-7167-2021-0853. eCollection 2022.
7
Perceived Mistreatment in Health Care Settings and its Relationship with HIV Clinical Outcomes in HIV-positive People who Use Drugs in Vancouver, Canada.在加拿大温哥华,接受过健康护理的 HIV 阳性吸毒者感知到的虐待及其与 HIV 临床结局的关系。
AIDS Behav. 2023 May;27(5):1636-1646. doi: 10.1007/s10461-022-03895-z. Epub 2022 Nov 1.
8
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study.加拿大观察性队列研究(CANOC)中2000年至2016年联合抗逆转录病毒疗法的使用趋势及治疗反应:一项纵向队列研究
Can J Hosp Pharm. 2022 Oct 3;75(4):309-316. doi: 10.4212/cjhp.3234. eCollection 2022 Fall.
9
Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada.在加拿大不列颠哥伦比亚省开展全省治疗即预防倡议前后,诊断出 HIV 的人群的医疗保健和治疗体验。
BMC Public Health. 2022 May 21;22(1):1022. doi: 10.1186/s12889-022-13415-2.
10
Improving Post-Release Care Engagement for People Living with HIV Involved in the Criminal Justice System: A Systematic Review.改善参与刑事司法系统的艾滋病毒感染者的释放后护理参与度:系统评价。
AIDS Behav. 2022 May;26(5):1607-1617. doi: 10.1007/s10461-021-03513-4. Epub 2021 Oct 27.
Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study.
从常规 HIV 基因分型中实时监测 HIV 传播热点:实施案例研究。
Lancet HIV. 2016 May;3(5):e231-8. doi: 10.1016/S2352-3018(16)00046-1. Epub 2016 Apr 7.
4
Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.加拿大不列颠哥伦比亚省针对艾滋病毒的人群层面扩大高效抗逆转录病毒治疗的成本效益:一项建模研究。
Lancet HIV. 2015 Sep;2(9):e393-400. doi: 10.1016/S2352-3018(15)00127-7. Epub 2015 Jul 16.
5
Characterizing retention in HAART as a recurrent event process: insights into 'cascade churn'.将高效抗逆转录病毒疗法(HAART)中的留存率表征为一个复发事件过程:对“级联波动”的见解。
AIDS. 2015 Aug 24;29(13):1681-9. doi: 10.1097/QAD.0000000000000746.
6
Implementation of HIV treatment as prevention strategy in 17 Canadian sites: immediate and sustained outcomes from a 35-month Quality Improvement Collaborative.在加拿大17个地点将艾滋病毒治疗作为预防策略的实施:一项为期35个月的质量改进协作项目的即时和持续成果
BMJ Qual Saf. 2016 May;25(5):345-54. doi: 10.1136/bmjqs-2015-004269. Epub 2015 Jul 24.
7
The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.阿片类药物替代治疗和高效抗逆转录病毒疗法对注射毒品的艾滋病毒阳性者特定病因死亡风险的影响。
Clin Infect Dis. 2015 Oct 1;61(7):1157-65. doi: 10.1093/cid/civ476. Epub 2015 Jun 25.
8
The causal effect of opioid substitution treatment on HAART medication refill adherence.阿片类药物替代治疗对高效抗逆转录病毒治疗药物续方依从性的因果效应。
AIDS. 2015 May 15;29(8):965-73. doi: 10.1097/QAD.0000000000000642.
9
Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions.针对资源有限环境的HIV即时检测的可行性:挑战与解决方案。
BMC Med. 2014 Sep 8;12:173. doi: 10.1186/s12916-014-0173-7.
10
Process monitoring of an HIV treatment as prevention program in British Columbia, Canada.加拿大不列颠哥伦比亚省一项将艾滋病治疗作为预防手段的项目的过程监测。
J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):e94-e109. doi: 10.1097/QAI.0000000000000293.